Health - US

FDA Authorizes COVID Drug Pemgarda for High-Risk Patients A Yale Medicine expert explains the significance of a new preventive medication to protect certain immunocompromised people against COVID-19. Yale Medicine

The Food and Drug Administration (FDA) granted an emergency use authorization (EUA) to a medicine meant to protect certain immunocompromised people against COVID-19.

Study finds many younger people from high income neighborhoods jumped the eligibility queue for COVID-19 vaccines in NYC

Despite vaccine shortages, many younger people in New York City accessed vaccines ahead of schedule, particularly in high-income areas, according to new research at Columbia University Mailman School of Public Health.

Low-income areas with high proportions of older people demonstrated lower coverage rates than wealthier areas in the first three months of vaccine rollout, and higher mortality over the year. The findings are published in the Journal of Urban Health.

...

US flu, COVID, RSV activity continues to recede With the drop in flu activity gaining momentum, several parts of the US are now below their regional baselines. CIDRAP

Respiratory virus activity in the United States is still elevated but continues to decline, with only 6 jurisdiction reporting high levels, down from 10 the previous week, the Centers for Disease Control and Prevention (CDC) said today in its data updates.

...